WallStSmart

Akso Health Group ADR (AHG)vsCencora Inc. (COR)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Cencora Inc. generates 2439169% more annual revenue ($337.40B vs $13.83M). COR leads profitability with a 1.0% profit margin vs -135.0%. COR earns a higher WallStSmart Score of 62/100 (C+).

AHG

Avoid

12

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 5.3Quality: 9.0
Piotroski: 5/9Altman Z: 12.00

COR

Buy

62

out of 100

Grade: C+

Growth: 6.0Profit: 6.0Value: 5.3Quality: 3.8
Piotroski: 5/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AHGUndervalued (+8.4%)

Margin of Safety

+8.4%

Fair Value

$1.54

Current Price

$1.33

$0.21 discount

UndervaluedFair: $1.54Overvalued
CORSignificantly Overvalued (-85.6%)

Margin of Safety

-85.6%

Fair Value

$193.43

Current Price

$359.03

$165.60 premium

UndervaluedFair: $193.43Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHG2 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
12.0010/10

Safe zone — low bankruptcy risk

COR4 strengths · Avg: 8.8/10
Return on EquityProfitability
94.6%10/10

Every $100 of equity generates 95 in profit

Market CapQuality
$66.67B9/10

Large-cap with strong market position

PEG RatioValuation
0.778/10

Growing faster than its price suggests

Free Cash FlowQuality
$2.70B8/10

Generating 2.7B in free cash flow

Areas to Watch

AHG4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.16B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-89.4%2/10

ROE of -89.4% — below average capital efficiency

Revenue GrowthGrowth
-12.9%2/10

Revenue declined 12.9%

COR4 concerns · Avg: 2.8/10
Price/BookValuation
18.6x4/10

Trading at 18.6x book value

Profit MarginProfitability
1.0%3/10

1.0% margin — thin

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Debt/EquityHealth
3.061/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : AHG

The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.

Bull Case : COR

The strongest argument for COR centers on Return on Equity, Market Cap, PEG Ratio. PEG of 0.77 suggests the stock is reasonably priced for its growth.

Bear Case : AHG

The primary concerns for AHG are EPS Growth, Market Cap, Return on Equity.

Bear Case : COR

The primary concerns for COR are Price/Book, Profit Margin, Operating Margin. Debt-to-equity of 3.06 is elevated, increasing financial risk. Thin 1.0% margins leave little buffer for downturns.

Key Dynamics to Monitor

AHG profiles as a turnaround stock while COR is a value play — different risk/reward profiles.

COR carries more volatility with a beta of 0.57 — expect wider price swings.

COR is growing revenue faster at 5.5% — sustainability is the question.

COR generates stronger free cash flow (2.7B), providing more financial flexibility.

Bottom Line

COR scores higher overall (62/100 vs 12/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Akso Health Group ADR

HEALTHCARE · MEDICAL DISTRIBUTION · China

Akso Health Group ADR is a leading entity in the healthcare sector, dedicated to providing innovative medical solutions and comprehensive patient care services. With a strong emphasis on advanced health technologies, the company is strategically positioned in the telehealth and personalized medicine markets, supported by a robust research and development framework. As it navigates the rapidly evolving healthcare landscape, Akso Health Group presents an attractive investment opportunity for institutional investors seeking to capitalize on transformative trends within the industry.

Visit Website →

Cencora Inc.

HEALTHCARE · MEDICAL DISTRIBUTION · USA

CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.

Want to dig deeper into these stocks?